soul trial oral semaglutide cardiovascular outcomes 2024 results mace PDF) Effects of on in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized Canadian Perspectives 2025 Whiteboard on

You're not writing a case study

this macro doesnt spike your blood sugar and can slow the digestion of carbs (like rice and potatoes)

While receptor levels, animal diet, dosing, and the presence of a GLP-1RA have a profound impact on insulin secretion and associated endocrine outcomes, the effects of dual or triple agonism of Y1-R and Y2-R, in the presence of a GLP-1RA remain unclear

[11] [16] Clinical observations suggest that semaglutide may improve liver enzyme levels in many patients, particularly those with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease or NAFLD)

These are adhesive patches you stick on your skin that claim to help with weight loss, but theyre not prescription GLP-1 drugs

Lean Mass Trajectory